Form4insider filings, from the source

Insider holders · CIK 0001270073

INTERCEPT PHARMACEUTICALS, INC. · ICPT

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Francesco Micheli10% Owner—6,095,5786,095,578Dec 3, 2018 · 4:34 pm ESTForm 4
Genextra S.p.A.10% Owner6,095,578—6,095,578Dec 3, 2018 · 4:31 pm ESTForm 4
Jonathan SilversteinDirector1,2591,120,3241,121,583Nov 27, 2015 · 9:02 pm ESTForm 4
OrbiMed Capital GP IV LLCDirector—1,120,6091,120,609Jul 21, 2015 · 9:25 pm EDTForm 4
ORBIMED ADVISORS LLCDirector—1,120,6091,120,609Jul 21, 2015 · 9:25 pm EDTForm 4
Samuel D IsalyDirector—1,120,6091,120,609Jul 21, 2015 · 9:25 pm EDTForm 4
Mark PruzanskiPresident & CEO573,768—573,768Jan 18, 2019 · 7:03 pm ESTForm 4
Srinivas AkkarajuDirector16,456210,937227,393Feb 21, 2019 · 8:33 pm ESTForm 4
David ShapiroChief Medical Officer40,543—40,543Mar 1, 2019 · 7:00 pm ESTForm 4
Jerome Benedict DursoChief Operating Officer34,046—34,046Feb 26, 2019 · 7:00 pm ESTForm 4
Barbara Gayle DuncanChief Accounting Officer30,661—30,661Oct 5, 2016 · 9:04 pm EDTForm 4
Sandip KapadiaCFO and Treasurer27,923—27,923Jan 18, 2019 · 7:03 pm ESTForm 4
Ryan T SullivanGeneral Counsel and Secretary27,829—27,829Feb 14, 2019 · 7:01 pm ESTForm 4
Lisa BrightPresident, International22,107—22,107Jan 18, 2019 · 7:00 pm ESTForm 4
Christian WeyerEVP, Research & Development19,107—19,107Mar 1, 2019 · 7:00 pm ESTForm 4
Gail CawkwellSVP, Med Affairs, Safety & PV17,849—17,849Feb 14, 2019 · 7:00 pm ESTForm 4
Richard J KimPresident US Comm & Strat Mktg17,737—17,737Jan 18, 2019 · 7:05 pm ESTForm 4
Rachel McMinnChief Strategy Officer16,875—16,875Oct 4, 2017 · 9:00 pm EDTForm 4
Daniel BradburyDirector13,429—13,429Jun 22, 2018 · 5:00 pm EDTForm 4
Paolo FundaroDirector13,285—13,285Jun 22, 2018 · 5:02 pm EDTForm 4
David A FordChief Human Resources Officer12,786—12,786Feb 11, 2019 · 7:00 pm ESTForm 4
Luciano AdoriniChief Scientific Officer12,608—12,608Oct 5, 2015 · 9:01 pm EDTForm 4
Keith Michael GottesdienerDirector6,788—6,788Jun 22, 2018 · 5:01 pm EDTForm 4
Luca BenattiDirector6,356—6,356Jun 22, 2018 · 5:00 pm EDTForm 4
Gino SantiniDirector5,714—5,714Jun 22, 2018 · 5:03 pm EDTForm 4
Glenn SblendorioDirector5,516—5,516Jun 22, 2018 · 5:04 pm EDTForm 4
Daniel G WelchDirector4,895—4,895Jun 22, 2018 · 5:02 pm EDTForm 4
Nancy Miller-RichDirector4,373—4,373Jun 22, 2018 · 5:01 pm EDTForm 4
Klaus R Dr VeitingerDirector2,816—2,816Nov 27, 2015 · 9:01 pm ESTForm 4
Daniel Paul ReganChief Commercial Officer1,264—1,264Feb 3, 2015 · 9:01 pm ESTForm 4
Nicole WilliamsDirector962—962Nov 23, 2015 · 9:01 pm ESTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.